You are here

niraparib

GlaxoSmithKline Keeps Oncology 2.0 Growth Plans on Track

Xconomy

Sat, 06/13/20 - 11:27 pm

belantamab mafodotin

immuno-oncology

GSK’s niraparib meets PFS goal in phase 3 PRIMA trial

Pharmaceutical Business Review

Tue, 10/1/19 - 09:56 am

clinicial trials

advanced ovarian cancer

Preliminary positive results for Phase I - II trial of Tesaro's Zejula with Keytruda in platinum-resistant ovarian cancer (TSRO)

CP Wire

Mon, 03/26/18 - 02:48 pm

platinum-resistant ovarian cancer

clinical trials vaccines

Preliminary positive results for Phase I - II trial of Tesaro's Zejula with Keytruda in platinum-resistant ovarian cancer

Mon, 03/26/18 - 02:41 pm

platinum-resistant ovarian cancer

clinical trials

Tesaro's PARP inhibitor approved in ovarian cancer

BioPharma Dive

Mon, 03/27/17 - 10:38 pm

PARP inhibitors

Tesaro sees a $5B market opportunity for its cancer drug

Bizjournals.com

Fri, 02/17/17 - 10:14 am

These 3 Little Biotechs Just Scored Big

Motley Fool

Tue, 10/11/16 - 09:33 pm

Celldex Therapeutics

renal cell carcinoma

Tesaro Enjoys A 'Ta-Dah' Moment

Seeking Alpha

Mon, 10/10/16 - 04:20 pm

Tesaro Drug Delays Recurrence of Ovarian Cancer, New Clinical Trial Shows

TheStreet.com

Sat, 10/8/16 - 03:49 pm

Gilead Sciences, Inc. Can Fancy TESARO Inc for Acquisition

Bidness, ETC

Tue, 09/13/16 - 11:38 am

Gilead Sciences

PARP inhibitors

An Overnight Double! Could These Drugmakers Be Next?

Motley Fool

Sat, 07/2/16 - 12:36 pm

PARP inhibitors

Clovis Oncology

This Biotech's Stock Just Doubled and It's Bad News for Sanofi

Fortune

Thu, 06/30/16 - 09:27 am

Tesaro Shares Surge 82% Because Drug Slows Ovarian Cancer

Forbes

Wed, 06/29/16 - 10:51 am

clinical trials

J&J grabs prostate cancer rights for Tesaro's niraparib in $500M deal

Fierce Biotech

Wed, 04/6/16 - 09:51 am

prostate cancer

Netupitant Results Could Roil Tesaro In May

Seeking Alpha

Mon, 05/6/13 - 10:48 am

Biotech All Stars Buy Castoff Experimental Merck Cancer Drug

Forbes

Wed, 06/6/12 - 03:30 pm